MedTrace Logo

Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis

NCT02923206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-09-30

No results posted yet for this study

Summary

This clinical investigation is a medical device trial to examine the safety and efficacy of TheraSorb sFlt-1 adsorber treatment of pregnant patients with preeclampsia.

Conditions

Interventions

DEVICE

TheraSorb sFlt-1 adsorber

Removal of excessive sFlt-1 from the plasma of subjects/ patients with therapeutic apheresis.

Sponsors & Collaborators

  • Cromsource

    collaborator INDUSTRY

  • Miltenyi Biomedicine GmbH

    lead INDUSTRY

Principal Investigators

  • Thomas Benzing, Prof. Dr. · University Clinic Cologne

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2024-08-20
Completion
2025-07-16

Countries

  • Germany
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02923206 on ClinicalTrials.gov